Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Tunica Albuginea who wrote (4374)	1/7/1998 7:47:00 AM
From: Zebra 365	Read Replies (2) \| Respond to of 23519

Tuna, Good post on why these drugs will not affect women. I would only add to emphasize that blood vessel changes are not necessary to sexual excitement or orgasm which are neurological functions. The separate nature of neruo- and vascular function would explain why these drugs should all be very effective in spinal cord injury, given an intact vasculature, and all have greatest failure in severe diabetes with it's combined neurological and blood vessel disease. I was going to say something about confusing cause and effect ie. I know how to make a dog happy....... just move it's tail back and forth. However MisLil asked a serious question and it deserved a serious response, which you gave. I refuse to get excited about an early release of earnings until the rumor is confirmed, but that should be quite a plus if true. Nothing goes down forever, particularly not 10 dollar stocks with trailing earnings of a dollar. "Acapulco" is a great analogy for my slogan, "Buy on Fear, Sell on Greed". Zebra